Telomere attrition predominantly occurs in precursor lesions during in vivo carcinogenic process of the uterine cervix

被引:47
作者
Zhang, AJ
Wang, JL
Zheng, BY
Fang, XL
Ångström, T
Liu, C
Li, XD
Erlandsson, F
Björkholm, M
Nordenskjörd, M
Gruber, A
Wallin, KL [1 ]
Xu, DW
机构
[1] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med, CMM, SE-17176 Stockholm, Sweden
[2] Univ Umea Hosp, Cytol Lab, SE-90187 Umea, Sweden
[3] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Div Hematol, SE-17176 Stockholm, Sweden
[4] Karolinska Univ Hosp, Karolinska Inst, Dept Pathol & Oncol, SE-17176 Stockholm, Sweden
[5] Peking Univ, Peoples Hosp, Dept Gynecol, Beijing 100083, Peoples R China
[6] Shandong Univ, Qilu Hosp, Dept Urol, Jinan 250108, Peoples R China
[7] Karolinska Univ Hosp, Karolinska Inst, Dept Urol, SE-17176 Stockholm, Sweden
关键词
cervical cancer; HPV; genomic instability; telomere erosion; telomerase;
D O I
10.1038/sj.onc.1207527
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although human papillomavirus (HPV) has been defined as the pathogen for cervical carcinomas, molecular events underlying the oncogenic process are unclear. As telomere dysfunction-mediated chromosomal instability and telomerase activation have been suggested as key events in carcinogenesis, we dissected the dynamic changes in telomere length, checkpoint response, and temporal pro. le of telomerase expression during the evolution from precursor lesions ( cervical intraepithelial neoplasia, CINs) to invasive cancers of the uterine cervix in sequential samples from 16 patients. Telomeres were significantly shortened in all CIN samples and no further substantial attritions occurred in most cases with the acquisition of malignant phenotype. Very short telomeres were coupled with constitutive activation of the DNA damage response pathway (Chk2 phosphorylation) and increased cellular proliferation in those cervical specimens. Telomerase reverse transcriptase ( hTERT) expression was preferably induced at advanced CINs or invasive cancers. The present finding demonstrates that excessive telomere shortening predominantly occurs in the early carcinogenesis of the uterine cervix largely prior to telomerase activation. Widespread over-erosion of telomeres or telomere dysfunction in very early stages of cervical tumorigenesis might fuel transformation processes by driving chromosomal instability.
引用
收藏
页码:7441 / 7447
页数:7
相关论文
共 41 条
  • [1] Anderson S, 1997, AM J PATHOL, V151, P25
  • [2] Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
    Artandi, SE
    Chang, S
    Lee, SL
    Alson, S
    Gottlieb, GJ
    Chin, L
    DePinho, RA
    [J]. NATURE, 2000, 406 (6796) : 641 - 645
  • [3] Aubele M, 1998, CANCER CYTOPATHOL, V84, P375, DOI 10.1002/(SICI)1097-0142(19981225)84:6<375::AID-CNCR10>3.0.CO
  • [4] 2-1
  • [5] Human papillomavirus and cervical cancer
    Burd, EM
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2003, 16 (01) : 1 - +
  • [6] Modeling chromosomal instability and epithelial carcinogenesis in the telomerase-deficient mouse
    Chang, S
    Khoo, C
    DePinho, RA
    [J]. SEMINARS IN CANCER BIOLOGY, 2001, 11 (03) : 227 - 238
  • [7] TELOMERE SHORTENING ASSOCIATED WITH CHROMOSOME INSTABILITY IS ARRESTED IN IMMORTAL CELLS WHICH EXPRESS TELOMERASE ACTIVITY
    COUNTER, CM
    AVILION, AA
    LEFEUVRE, CE
    STEWART, NG
    GREIDER, CW
    HARLEY, CB
    BACCHETTI, S
    [J]. EMBO JOURNAL, 1992, 11 (05) : 1921 - 1929
  • [8] The shortest telomeres drive karyotype evolution in transformed cells
    der-Sarkissian, H
    Bacchetti, S
    Cazes, L
    Londoño-Vallejo, JA
    [J]. ONCOGENE, 2004, 23 (06) : 1221 - 1228
  • [9] 53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer
    DiTullio, RA
    Mochan, TA
    Venere, M
    Bartkova, J
    Sehested, M
    Bartek, J
    Halazonetis, TD
    [J]. NATURE CELL BIOLOGY, 2002, 4 (12) : 998 - 1002
  • [10] Allelic deletion at 11q23.3-q25 is an early event in cervical neoplasia
    Evans, MF
    Koreth, J
    Bakkenist, CJ
    Herrington, CS
    McGee, JOD
    [J]. ONCOGENE, 1998, 16 (19) : 2557 - 2564